SEC Filings | EyePoint Pharmaceuticals

Form	Description	Filing date	View
DEFA14A	Additional proxy soliciting materials - definitive	Apr 17, 2008	View HTML 0001193125-08-083623.pdf 0001193125-08-083623.rtf 0001193125-08-083623.xls
8-K	Report of unscheduled material events or corporate event	Apr 17, 2008	View HTML 0001193125-08-083622.pdf 0001193125-08-083622.rtf 0001193125-08-083622.xls
PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	Apr 17, 2008	View HTML 0001193125-08-083633.pdf 0001193125-08-083633.rtf 0001193125-08-083633.xls
8-K	Report of unscheduled material events or corporate event	Mar 20, 2008	View HTML 0001193125-08-061779.pdf 0001193125-08-061779.rtf 0001193125-08-061779.xls
10-Q	Quarterly report which provides a continuing view of a company's financial position	Feb 11, 2008	View HTML 0001193125-08-025780.pdf 0001193125-08-025780.rtf 0001193125-08-025780.xls
SC 13G/A	An amendment to the SC 13G filing	Feb 08, 2008	View HTML 0001085146-08-000310.pdf 0001085146-08-000310.rtf 0001085146-08-000310.xls
8-K	Report of unscheduled material events or corporate event	Jan 31, 2008	View HTML 0001193125-08-016834.pdf 0001193125-08-016834.rtf 0001193125-08-016834.xls
8-K	Report of unscheduled material events or corporate event	Jan 30, 2008	View HTML 0001193125-08-015230.pdf 0001193125-08-015230.rtf 0001193125-08-015230.xls
8-K	Report of unscheduled material events or corporate event	Jan 02, 2008	View HTML 0001193125-08-000261.pdf 0001193125-08-000261.rtf 0001193125-08-000261.xls
8-K	Report of unscheduled material events or corporate event	Nov 30, 2007	View HTML 0001193125-07-257018.pdf 0001193125-07-257018.rtf 0001193125-07-257018.xls

Data provided by Kaleidoscope.